| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 |
| filingDate |
1998-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b0a5c499ab1b7e69be8f253d558a73f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6726b40b2ab1b1359ffc68f24325d04a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6804fcb4b11eea9d67a09672559ce9b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1920bdcaa7ad9433dcdaf93351301434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44fca99b6147410072ed5d17a13bef30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d2df0bc549b4b7de4de61135c6cf854 |
| publicationDate |
2003-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AP-1189-A |
| titleOfInvention |
C-4"-substituted macrolide derivatives. |
| abstract |
This invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts thereof. The compounds of formula 1 are potent antibacterial agents that may be used to treat various bacterial infections and disorders related to such infections. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating bacterial infections by administering the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1 and to intermediates useful in such preparation. |
| priorityDate |
1997-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |